The stock market is still rangebound. Tesla dived as Elon Musk plays DOGE ball. DoorDash, Upstart are earnings winners late.

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Edwards Lifesciences stock fell slightly late Tuesday after the company kept its outlook for 2025 despite beating ...

The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...

Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, rebounding from a sell-off.

Researchers have found in a new study that common antibiotic Vancomycin may also be effective in treating individuals with a ...

According to a recent study, male patients with inflammatory bowel disease face a higher risk for ischemic heart diseases.

Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

The inflammatory bowel disease (IBD), develops due to an incurable autoimmune liver disease called primary sclerosing ...

A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively ...